Skip to main navigation Skip to search Skip to main content

Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis

  • Constantin Von Zur Muhlen
  • , Dominik von Elverfeldt
  • , J A Moeller
  • , Robin P Choudhury
  • , D Paul
  • , Christoph Eugen Hagemeyer
  • , Manfred Olschewski
  • , Anne-Katrin Becker
  • , Irene Neudorfer
  • , Nicole Bassler
  • , Meike Schwarz
  • , Christoph Bode
  • , Karlheinz Peter

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Platelets are the key to thrombus formation and play a role in the development of atherosclerosis. Noninvasive imaging of activated platelets would be of great clinical interest. Here, we evaluate the ability of a magnetic resonance imaging (MRI) contrast agent consisting of microparticles of iron oxide (MPIOs) and a single-chain antibody targeting ligand-induced binding sites (LIBS) on activated glycoprotein IIb/IIIa to image carotid artery thrombi and atherosclerotic plaques. Methods and results - Anti-LIBS antibody or control antibody was conjugated to 1-?m MPIOs (LIBS MPIO/control MPIO). Nonocclusive mural thrombi were induced in mice with 6 ferric chloride. MRI (at 9.4 T) was performed once before and repeatedly in 12-minute-long sequences after =LIBS MPIO/control MPIO injection. After 36 minutes, a significant signal void, corresponding to MPIO accumulation, was observed with LIBS MPIOs but not control MPIOs (P
Original languageEnglish
Pages (from-to)258 - 267
Number of pages10
JournalCirculation
Volume118
Issue number3
DOIs
Publication statusPublished - 2008
Externally publishedYes

Cite this